Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > total buying opportunity!
View:
Post by redatnight on Feb 02, 2016 4:10pm

total buying opportunity!

In may...our balance sheet will show an eps (positive)..not sure how much...but the market for urocidin is huge...just read Doug loes Ispen synopsis on mcna's potential..its not a loss for everybody...if you look at it, you should be seeing a buying opportunity!
Comment by bullmarkets on Feb 02, 2016 4:39pm
it is a buy today.. have traded this several times -- by feb 12 ( earnings).. this will be 15-20  .. the game is not over..
Comment by vega509 on Feb 02, 2016 4:42pm
I wish I could share in your optimism, but where are the sales going to come from? has Urocidin or MCNA been approved anywhere? has Ispen made any progrees in Europe? another PIII trial would take years, and cost many more $millions than Telesta has. I'm not sure what is required to market in Europe, Asia, or the rest of the world, but the FDA has basically cut off any lifeline we had in the ...more  
Comment by redatnight on Feb 02, 2016 4:49pm
It is elementary my dear watson's...time will tell...this hugely undervalued company will someday get the credit it deserves....just give it time, and it will all be fine...I promise! red
Comment by PSB on Feb 02, 2016 5:37pm
Redatnight...... you stated this company "will someday get the credit it deserves" and "to just give it time". Do you have any idea how long some of us loyal, long term shareholders have waited for this company to deliver on any one of it's promising products. I have owned this for years with hopes that either Econiche or Urocidin would be a successful product brought to ...more  
Comment by ericshun on Feb 02, 2016 5:41pm
PREACH! Extremely poor planning and execution by management. Huge overnight imo
Comment by redatnight on Feb 02, 2016 5:48pm
Hey PSB I am as pissed as you are if not more. But a drug that cures cancer (4th leading cancer killer) cmon' eventually they will get their sh*t together and produce some revenue and profit...I know PSB that we are down to our last widjit (urocidin) but think please in months not days...red
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities